Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Rheumatoid Arthritis

  Free Subscription


14.10.2019

38 Clin Exp Rheumatol
2 PLoS One
9 Z Rheumatol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Exp Rheumatol

  1. MORENO-QUISPE LA, Velarde-Grados IVN, Guzman-Avalos M, De Arriba L, et al
    Prevalence of sicca syndrome in the Peruvian population.
    Clin Exp Rheumatol. 2019;37 Suppl 118:65-69.
    PubMed     Text format     Abstract available

  2. PARK Y, Lee J, Koh JH, Sung YK, et al
    Distinct clinical characteristics of anti-Ro/SSA-negative primary Sjogren's syndrome: data from a nationwide cohort for Sjogren's syndrome in Korea.
    Clin Exp Rheumatol. 2019;37 Suppl 118:107-113.
    PubMed     Text format     Abstract available

  3. XIAO F, Han M, Wang X, Gong X, et al
    Animal models of Sjogren's syndrome: an update.
    Clin Exp Rheumatol. 2019;37 Suppl 118:209-216.
    PubMed     Text format     Abstract available

  4. ZABOTTI A, Zandonella Callegher S, Gandolfo S, Valent F, et al
    Hyperechoic bands detected by salivary gland ultrasonography are related to salivary impairment in established Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:146-152.
    PubMed     Text format     Abstract available

  5. LEWIS I, Hackett KL, Ng WF, Ellis J, et al
    A two-phase cohort study of the sleep phenotype within primary Sjogren's syndrome and its clinical correlates.
    Clin Exp Rheumatol. 2019;37 Suppl 118:78-82.
    PubMed     Text format     Abstract available

  6. CALLHOFF J, Thiele K, Dorner T, Zink A, et al
    Trends in employment and hospitalisation in patients with Sjogren's syndrome 1996-2016: results from the German National database.
    Clin Exp Rheumatol. 2019;37 Suppl 118:83-89.
    PubMed     Text format     Abstract available

  7. INANC N, Sahinkaya Y, Mumcu G, Ture Ozdemir F, et al
    Evaluation of salivary gland ultrasonography in primary Sjogren's syndrome: does it reflect clinical activity and outcome of the disease?
    Clin Exp Rheumatol. 2019;37 Suppl 118:140-145.
    PubMed     Text format     Abstract available

  8. PEZOULAS VC, Kourou KD, Kalatzis F, Exarchos TP, et al
    Enhancing medical data quality through data curation: a case study in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:90-96.
    PubMed     Text format     Abstract available

  9. VAN GINKEL MS, Haacke EA, Bootsma H, Arends S, et al
    Presence of intraepithelial B-lymphocytes is associated with the formation of lymphoepithelial lesions in salivary glands of primary Sjogren's syndrome patients.
    Clin Exp Rheumatol. 2019;37 Suppl 118:42-48.
    PubMed     Text format     Abstract available

  10. FASANO S, Isenberg DA
    Present and novel biologic drugs in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:167-174.
    PubMed     Text format     Abstract available

  11. RUWAARD J, Marsman AF, Nurmohamed MT, van der Horst-Bruinsma IE, et al
    Antidrug antibody detection for adalimumab depends on the type of assay used: an experimental approach to help clinicians interpret diagnostic data.
    Clin Exp Rheumatol. 2019;37:756-761.
    PubMed     Text format     Abstract available

  12. SPOERL D, Roux-Lombard P
    Are antibodies against La (SSB) no longer useful for the diagnosis of Sjogren's syndrome?
    Clin Exp Rheumatol. 2019;37 Suppl 118:252-253.
    PubMed     Text format    

  13. YAN T, Shen J, Chen J, Zhao M, et al
    Differential expression of miR-17-92 cluster among varying histological stages of minor salivary gland in patients with primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:49-54.
    PubMed     Text format     Abstract available

  14. VINCENT FB, Bubicich M, Downie-Doyle S, Mackay F, et al
    Serum soluble Fas and Fas ligand (FasL) in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:254-256.
    PubMed     Text format    

  15. TALOTTA R, Mercurio V, Bongiovanni S, Vittori C, et al
    Evaluation of salivary and plasma microRNA expression in patients with Sjogren's syndrome, and correlations with clinical and ultrasonographic outcomes.
    Clin Exp Rheumatol. 2019;37 Suppl 118:70-77.
    PubMed     Text format     Abstract available

  16. MARTIN-MARTINEZ MA, Castaneda S, Gonzalez-Juanatey C, Sanchez-Alonso F, et al
    Incidence of first cardiovascular event in Spanish patients with inflammatory rheumatic diseases: prospective data from the CARMA project.
    Clin Exp Rheumatol. 2019;37:731-739.
    PubMed     Text format     Abstract available

  17. OLIVARES-MARTINEZ E, Hernandez-Ramirez DF, Nunez-Alvarez CA, Llorente L, et al
    alpha-enolase is an antigenic target in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:29-35.
    PubMed     Text format     Abstract available

  18. ALUNNO A, Ibba-Manneschi L, Bistoni O, Cipriani S, et al
    Angiogenic T cells in primary Sjogren's syndrome: a double-edged sword?
    Clin Exp Rheumatol. 2019;37 Suppl 118:36-41.
    PubMed     Text format     Abstract available

  19. MARKETOS N, Cinoku I, Rapti A, Mavragani CP, et al
    Type I interferon signature in Sjogren's syndrome: pathophysiological and clinical implications.
    Clin Exp Rheumatol. 2019;37 Suppl 118:185-191.
    PubMed     Text format     Abstract available

  20. GOULES AV, Exarchos TP, Pezoulas VC, Kourou KD, et al
    Sjogren's syndrome towards precision medicine: the challenge of harmonisation and integration of cohorts.
    Clin Exp Rheumatol. 2019;37 Suppl 118:175-184.
    PubMed     Text format     Abstract available

  21. HARRIS VM, Scofield RH, Sivils KL
    Genetics in Sjogren's syndrome: where we are and where we go.
    Clin Exp Rheumatol. 2019;37 Suppl 118:234-239.
    PubMed     Text format     Abstract available

  22. CAFARO G, Croia C, Argyropoulou OD, Leone MC, et al
    One year in review 2019: Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:3-15.
    PubMed     Text format     Abstract available

  23. ALUNNO A, Carubbi F, Bartoloni E, Cipriani P, et al
    The kaleidoscope of neurological manifestations in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:192-198.
    PubMed     Text format     Abstract available

  24. GANDOLFO S, De Vita S
    Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:199-208.
    PubMed     Text format     Abstract available

  25. BARTOLONI E, Baldini C, Ferro F, Alunno A, et al
    Application of artificial neural network analysis in the evaluation of cardiovascular risk in primary Sjogren's syndrome: a novel pathogenetic scenario?
    Clin Exp Rheumatol. 2019;37 Suppl 118:133-139.
    PubMed     Text format     Abstract available

  26. SEGHIERI C, Lupi E, Exarchos TP, Ferro F, et al
    Variation in primary Sjogren's syndrome care among European countries.
    Clin Exp Rheumatol. 2019;37 Suppl 118:27-28.
    PubMed     Text format    

  27. CECCHETTINI A, Finamore F, Puxeddu I, Ferro F, et al
    Salivary extracellular vesicles versus whole saliva: new perspectives for the identification of proteomic biomarkers in Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:240-248.
    PubMed     Text format     Abstract available

  28. GRIGORIADOU S, Chowdhury F, Pontarini E, Tappuni A, et al
    B cell depletion with rituximab in the treatment of primary Sjogren's syndrome: what have we learnt?
    Clin Exp Rheumatol. 2019;37 Suppl 118:217-224.
    PubMed     Text format     Abstract available

  29. GOULES A, Geetha D, Arend LJ, Baer AN, et al
    Renal involvement in primary Sjogren's syndrome: natural history and treatment outcome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:123-132.
    PubMed     Text format     Abstract available

  30. TZIOUFAS AG, Goules AV
    The necessity of novel biomarkers in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:16-18.
    PubMed     Text format    

  31. RETAMOZO S, Acar-Denizli N, Rasmussen A, Horvath IF, et al
    Systemic manifestations of primary Sjogren's syndrome out of the ESSDAI classification: prevalence and clinical relevance in a large international, multi-ethnic cohort of patients.
    Clin Exp Rheumatol. 2019;37 Suppl 118:97-106.
    PubMed     Text format     Abstract available

  32. ARGYROPOULOU OD, Chatzis LG, Rontogianni D, Tzioufas AG, et al
    Autoimmune epithelitis beyond the exocrine glands: an unusual case of anti-Ro/La and Scl-70 lymphocytic interstitial pneumonia.
    Clin Exp Rheumatol. 2019;37 Suppl 118:249-251.
    PubMed     Text format     Abstract available

  33. HAMMENFORS DS, Causevic H, Assmus J, Brun JG, et al
    Assessment of major salivary gland ultrasonography in Sjogren's syndrome. A comparison between bedside and post-examination evaluations.
    Clin Exp Rheumatol. 2019;37 Suppl 118:153-158.
    PubMed     Text format     Abstract available

  34. MAARSE F, Jager DHJ, Alterch S, Korfage A, et al
    Sjogren's syndrome is not a risk factor for periodontal disease: a systematic review.
    Clin Exp Rheumatol. 2019;37 Suppl 118:225-233.
    PubMed     Text format     Abstract available

  35. GANDOLFO S, Bulfoni M, Fabro C, Russi S, et al
    Thymic stromal lymphopoietin expression from benign lymphoproliferation to malignant B-cell lymphoma in primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:55-64.
    PubMed     Text format     Abstract available

  36. ACAR-DENIZLI N, Kostov B, Ramos-Casals M
    The Big Data Sjogren Consortium: a project for a new data science era.
    Clin Exp Rheumatol. 2019;37 Suppl 118:19-23.
    PubMed     Text format    

  37. RAMOS-CASALS M, Maria A, Suarez-Almazor ME, Lambotte O, et al
    Sicca/Sjogren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).
    Clin Exp Rheumatol. 2019;37 Suppl 118:114-122.
    PubMed     Text format     Abstract available

  38. DE VITA S, Zabotti A, Gandolfo S
    Current limitations and ongoing initiatives to evaluate the activity, damage and outcome of primary Sjogren's syndrome.
    Clin Exp Rheumatol. 2019;37 Suppl 118:24-26.
    PubMed     Text format    


    PLoS One

  39. VILAR KM, Pereira MC, Tavares Dantas A, de Melo Rego MJB, et al
    Galectin-9 gene (LGALS9) polymorphisms are associated with rheumatoid arthritis in Brazilian patients.
    PLoS One. 2019;14:e0223191.
    PubMed     Text format     Abstract available

  40. TRAYLOR M, Knevel R, Cui J, Taylor J, et al
    Genetic associations with radiological damage in rheumatoid arthritis: Meta-analysis of seven genome-wide association studies of 2,775 cases.
    PLoS One. 2019;14:e0223246.
    PubMed     Text format     Abstract available


    Z Rheumatol

  41. DISCHEREIT G, Goronzy JE, Muller-Ladner U, Fetaj S, et al
    [Effects of serial mud baths on inflammatory rheumatic and degenerative diseases].
    Z Rheumatol. 2019;78:143-154.
    PubMed     Text format     Abstract available

  42. KRUSCHE M, Boro D, Bertolini J, Kotter I, et al
    [Rare erosive arthritis and dermatitis syndrome in Whipple's disease].
    Z Rheumatol. 2019;78:180-182.
    PubMed     Text format     Abstract available

  43. LORENZ HM, Wendler J, Krause A
    [Improvement of prognosis by timely treatment : Requirement: initial presentation within 6 weeks].
    Z Rheumatol. 2019;78:396-403.
    PubMed     Text format     Abstract available

  44. WITTE T
    [Sjogren's syndrome].
    Z Rheumatol. 2019;78:511-517.
    PubMed     Text format     Abstract available

  45. CALLHOFF J, Albrecht K, Hoffmann F, Poddubnyy D, et al
    [Reality of care for musculoskeletal diseases at the population level : Results of the PROCLAIR collaborative project. German version].
    Z Rheumatol. 2019;78:713-721.
    PubMed     Text format     Abstract available

  46. ALBRECHT K, Callhoff J, Zink A
    [Long-term trends in rheumatology care : Achievements and deficits in 25 years of the German national rheumatology database].
    Z Rheumatol. 2019;78:703-712.
    PubMed     Text format     Abstract available

  47. SCHWARTING A, Dreher M, Assmann G, Witte T, et al
    [Experiences and results from Rheuma-VOR].
    Z Rheumatol. 2019;78:743-752.
    PubMed     Text format     Abstract available

  48. FREIER D, Strehl C, Buttgereit F
    [Oral glucocorticoids : Therapeutic use and treatment monitoring in inflammatory rheumatic diseases].
    Z Rheumatol. 2019;78:775-788.
    PubMed     Text format     Abstract available

  49. EDELMANN E, Schuch F, Kalthoff L, Zinke S, et al
    [Special treatment in rheumatology-cross-sectoral quality-oriented selective contracts].
    Z Rheumatol. 2019;78:429-438.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Rheumatoid Arthritis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: